Serum thymulin in human zinc deficiency.
Level 4 - case-series / case-control
Small non-randomized before-after experimental and observational series
PubMed 3262625 · doi:10.1172/JCI113717
What was done
Researchers measured serum thymulin activity and immune cell parameters before and after zinc supplementation across three groups of adults with mild zinc deficiency diagnosed via leukocyte and platelet zinc levels (despite normal plasma zinc): 2 volunteers undergoing experimental dietary zinc depletion, 6 subjects with sickle cell anemia, and 6 non-sickle cell anemia subjects.
What was found
The abstract reports directional changes without numeric values or statistical confidence intervals. Serum thymulin activity decreased during mild zinc deficiency and was restored by in vivo and in vitro zinc supplementation. In the experimental dietary depletion model, mild deficiency led to an increase in T101- sIg- cells, a decrease in the T4+/T8+ ratio, and decreased IL-2 activity, all of which reversed with zinc repletion. Similar reversible alterations in lymphocyte subpopulations occurred in the sickle cell group.
Why it matters
The study suggests serum thymulin activity is a sensitive functional marker of mild cellular zinc deficiency even when routine plasma zinc concentrations appear normal, providing a biological mechanism for zinc-dependent T-cell dysfunction.
Limits
Sample size is extremely small (total n = 14 across three distinct groups, with only 2 dietary depletion subjects). The study lacked a randomized control group or blinding, and the abstract provides no numerical data, baseline values, or p-values.
Cited by
- supports Thymulin levels decline as the first sign of zinc depletion, prior to drops in red blood cell zinc or serum zinc.